Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Single-base LOH can be used as Specific Marker to Classify BRCAx Familial Breast Cancer into More Homogenous Subtypes.

Literature DB >> 28117528

Single-base LOH can be used as Specific Marker to Classify BRCAx Familial Breast Cancer into More Homogenous Subtypes.

Bradley Downs¹, Fengxia Xiao¹, Yeong C Kim¹, Pei Xian Chen², Dali Huang³, Elizabeth A Fleissner³, Kenneth Cowan³, San Ming Wang¹.

Abstract

Entities: Disease Gene Species

Mesh：

Substances：
Biomarkers

Year: 2017 PMID： 28117528 PMCID： PMC5505784 DOI： 10.1111/tbj.12777

Source DB: PubMed Journal: Breast J ISSN： 1075-122X Impact factor: 2.431

× No keyword cloud information.

16 in total

1. Transcriptional characteristics of familial non-BRCA1/BRCA2 breast tumors.

Authors: Ricardo Fernández-Ramires; Gonzalo Gómez; Iván Muñoz-Repeto; Loris de Cecco; Gemma Llort; Alicia Cazorla; Ignacio Blanco; Manuela Gariboldi; Marco Alessandro Pierotti; Javier Benítez; Ana Osorio
Journal: Int J Cancer Date: 2010-10-08 Impact factor: 7.396

2. A non-BRCA1/2 hereditary breast cancer sub-group defined by aCGH profiling of genetically related patients.

Authors: M A Didraga; E H van Beers; S A Joosse; K I M Brandwijk; R A Oldenburg; L F A Wessels; F B L Hogervorst; M J Ligtenberg; N Hoogerbrugge; S Verhoef; P Devilee; P M Nederlof
Journal: Breast Cancer Res Treat Date: 2011-02-01 Impact factor: 4.872

Review 3. Pathology of hereditary breast cancer.

Authors: Leonard Da Silva; Sunil R Lakhani
Journal: Mod Pathol Date: 2010-05 Impact factor: 7.842

Review 4. Individualized medicine from prewomb to tomb.

Authors: Eric J Topol
Journal: Cell Date: 2014-03-27 Impact factor: 41.582

5. Loss of heterozygosity analysis at the BRCA loci in tumor samples from patients with familial breast cancer.

Authors: Ana Osorio; Miguel de la Hoya; Raquel Rodríguez-López; Angel Martínez-Ramírez; Alicia Cazorla; Juan José Granizo; Manel Esteller; Carmen Rivas; Trinidad Caldés; Javier Benítez
Journal: Int J Cancer Date: 2002-05-10 Impact factor: 7.396

6. Immunohistochemical characteristics defined by tissue microarray of hereditary breast cancer not attributable to BRCA1 or BRCA2 mutations: differences from breast carcinomas arising in BRCA1 and BRCA2 mutation carriers.

Authors: José Palacios; Emiliano Honrado; Ana Osorio; Alicia Cazorla; David Sarrió; Alicia Barroso; Sandra Rodríguez; Juan C Cigudosa; Orland Diez; Carmen Alonso; Enrique Lerma; Lydia Sánchez; Carmen Rivas; Javier Benítez
Journal: Clin Cancer Res Date: 2003-09-01 Impact factor: 12.531

7. Distinct genomic aberration patterns are found in familial breast cancer associated with different immunohistochemical subtypes.

Authors: L Melchor; E Honrado; M J García; S Alvarez; J Palacios; A Osorio; K L Nathanson; J Benítez
Journal: Oncogene Date: 2007-12-10 Impact factor: 9.867

8. Immunohistochemical classification of non-BRCA1/2 tumors identifies different groups that demonstrate the heterogeneity of BRCAX families.

Authors: Emiliano Honrado; Ana Osorio; Roger L Milne; María F Paz; Lorenzo Melchor; Alberto Cascón; Miguel Urioste; Alicia Cazorla; Orland Díez; Enrique Lerma; Manel Esteller; José Palacios; Javier Benítez
Journal: Mod Pathol Date: 2007-09-21 Impact factor: 7.842